Fosun was founded in 1992. After more than 30 years of development, Fosun has become a global innovation-driven consumer group. Adhering to the mission of creating happier lives for families worldwide, Fosun is committed to creating a global happiness ecosystem fulfilling the needs of families worldwide in Health, Happiness, and Wealth. In 2007, Fosun International was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK). As of 31 December 2025, Fosun International’s total assets amounted to RMB716.2 billion, and its latest MSCI ESG rating is AAA.

Long?standing commitment to the two core drivers of “globalization” and “innovation”

Rooted in China, Fosun has been developing globally while remaining committed to its two core drivers of “globalization” and “innovation”. Fosun is one of the few Chinese companies that is equipped with global operational and investment capabilities, and has built strong capabilities in technology and innovation. After more than a decade of dedicated effort, Fosun has steadily established a global business presence, focusing on and continuing to deepen in the household consumption industry.

The globalization journey of Fosun began with the listing of Fosun International. After 19 years since its listing, Fosun has established a business presence in more than 40 countries and regions around the world. In 2025, Fosun’s overseas revenue accounted for approximately 55% of its total revenue. Since 2022, the model of “global organization + local operations” has become more mature. Fosun has entered the 3.0 era of “Combining Global Resources with China’s Capabilities”, building global operational capabilities in “global presence, global research and development (R&D), global supply chain, and global commercialization” across its core businesses. Fosun’s globalization strategy means more than just “two-way engagement” between the global and Chinese markets. It extends to the endogenous development of its ecosystem enterprises both domestically and internationally, encouraging them to actively expand their businesses beyond their home markets.

Innovation serves as another core driver for Fosun’s development. In 2025, Fosun invested RMB7.8 billion in technology innovation. As its global innovation system integrating “independent R&D + investment incubation + ecosystem collaboration” became more mature, its innovative drugs ushered in a period of rapid growth. Over the years, Fosun has been committed to applying innovative technologies in product iteration, blockbuster product development, customer service, and customer engagement. By collaborating with governments at various levels, universities, and scientific research institutions, Fosun has fostered the in-depth integration of industry, academia, and research to maintain its cutting-edge competitiveness.

In the era of artificial intelligence (AI), Fosun fully embraces AI to drive a crucial shift from “business + AI” to “AI + business”, aiming to lead the industry in AI adoption. Fosun Pharma’s PharmAID decision intelligence platform and Henlius’ HAI Club have effectively enhanced drug R&D efficiency; Fosun Tourism Group’s (“FTG”) “AI G.O” intelligent system has optimized the entire vacation experience and enhanced operational efficiency; Fosun Insurance Portugal’s digital user base reached nearly 22% of Portugal’s population, with large AI models beginning to create business value across segments.

With over 30 years of extensive industrial operational experience, and leveraging its strengths in innovation and globalization, Fosun has collaborated with various partners to continuously deliver high-quality projects. Funded by the Taicang Municipal Government platform and managed by FTG, the Taicang Alps Resort Phase II project broke ground in June 2025. It is set to become a world-class new landmark for ice and snow tourism. The Hi•Chongqing project is a joint initiative between the Chongqing Municipal Government platform and FTG, with FTG responsible for renovation and operational management. Scheduled to open in 2026, it is set to become a large-scale indoor themed tourism and entertainment park.

Ongoing focus on the four major business segments: Health, Happiness, Wealth, and Intelligent Manufacturing

Fosun continues to strengthen its four major business segments of Health, Happiness, Wealth, and Intelligent Manufacturing, providing high-quality products and services to families worldwide. Its four core subsidiaries — Fosun Pharma, Yuyuan, Fosun Insurance Portugal, and FTG — accounted for 74% of the Group’s total revenue.

The Health segment focuses on the three major areas — biopharmaceuticals, devices & diagnostics, and healthcare services — to build a medical-grade, one-stop, all-scenario health ecosystem. Targeting unmet medical needs, Fosun Pharma’s strategic focus is on key therapeutic areas including oncology, immunology and inflammation, and neurodegenerative diseases, while actively expanding into cardiometabolic diseases and rare diseases. This approach enables the development of high valued competitive pipelines and comprehensive healthcare solutions. Meanwhile, Fosun Pharma continues to consolidate its core technical platforms including but not limited to antibodies and antibody-drug conjugates (ADCs), small molecules and cell therapies. Additionally, it actively advances cutting-edge therapeutic modalities such as radiopharmaceuticals and small nucleic acids. Its innovative products are now available in more than 90 countries and regions worldwide. In 2025, 16 indications of 7 innovative drugs were approved for marketing in China and overseas markets. HANSIZHUANG, HLX43, HLX22, and other marketed and pipeline innovative drugs have delivered several “world’s first” breakthroughs.

The Happiness segment centers on consumption and cultural tourism, aiming to build a global, industry-wide happiness ecosystem. Yuyuan leverages oriental lifestyle aesthetics to lead the trend of Chinese cultural revival. It has built a portfolio that spans jewelry and fashion, cultural retail, cultural food and dining, and national watch brands. Its national intangible cultural heritage project, the Yuyuan Lantern Festival, together with China time-honored brands such as Laomiao, Songhelou, Nanxiang Steamed Bun Restaurant, and Shede Spirits, have successfully expanded overseas. FTG has launched three major product lines — “Super Resort”, “Super Resort Complex”, and “Super Culture and Tourism Mall” — to deliver premium vacation experiences for families worldwide. Club Med has sales and marketing operations in more than 40 countries and regions across six continents and operates 67 resorts. In 2025, Club Med once again achieved record-high revenue. Atlantis Sanya has become an iconic destination in Hainan’s tourism sector, consistently maintaining high occupancy rates throughout the year.

The Wealth segment focuses on the two major fields of insurance and asset management. Fosun Insurance Portugal has consistently maintained its leading position in the Portuguese market while accelerating its international development, with international operations accounting for over 30% of its consolidated businesses. Peak Reinsurance has continued to expand into emerging markets such as India, while further increasing its penetration rate in mature markets in Europe and North America. In the Chinese market, Fosun United Health Insurance and Pramerica Fosun Life Insurance have entered a phase of profitable growth, with both the scale and quality of profit reaching a new level in 2025. In addition, Fosun has accelerated its deployment of new financial business driven by cutting-edge technologies.

The Intelligent Manufacturing segment leverages strategic resources, functional new materials, and intelligent manufacturing as its core to empowers high-end, intelligent, and green transformation of the industry. Centered on strategic resources, Hainan Mining is building a global presence across three core areas: “iron ore + oil and gas + new energy”. Wansheng applies its core technology in advanced materials to support the upgrading of high-end manufacturing. Easun Technology focuses on industrial automation and digitalization, positioning itself as a leader in intelligent manufacturing systems.

Enduring dedication to the corporate values of “Self-improvement, Teamwork, Performance, and Contribution to Society”

For more than 30 years since its establishment, Fosun has consistently upheld its corporate values of “Self-improvement, Teamwork, Performance, and Contribution to Society”. Fosun has diligently fulfilled its corporate social responsibility, achieving outstanding performance in environmental, social, and governance (ESG) practices. Fosun International has received an MSCI ESG rating of AAA and has been included in S&P Global’s Sustainability Yearbook 2026. Fosun Foundation carries out philanthropic initiatives across global emergency relief, rural revitalization, health promotion, youth entrepreneurship, education, and culture & art. Since the launch of the Rural Doctors Program at the end of 2017, the program has covered 78 counties in 16 provinces, cities, and autonomous regions across the country, supporting 25,000 rural doctors and benefiting 3 million rural families. In global public health, as of the end of 2025, Fosun Pharma had supplied a cumulative total of over 440 million doses of artesunate for injection globally, saving more than 88 million patients with severe malaria worldwide.